Toxoplasma gondii is capable of invading and multiplying within murine peritoneal macrophages. Previous studies have shown that treatment of macrophage monolayers with recombinant gamma interferon but not tumor necrosis factor (TNF) is associated with intracellular killing of T. gondii by macrophages. Furthermore, infection of macrophages with T. gondii prevents their stimulation for mycobactericidal activity by TNF. Since transforming growth factor 13 (TGF-I) is known to suppress a number of functions in macrophages, we investigated the influence of infection with T. gondii on macrophage TNF receptors and on production of TGF-1. Infection with T. gondii was associated with increased production of TGF-13 and downregulation of TNF receptors. This effect was observed early after infection and was partially inhibited by anti-TGF-1 antibody.
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Toxoplasma gondii is an obligate intracellular protozoan parasite capable of invading all cells in the human body. It multiplies within a vacuole in the cytoplasm of its host cell (1, 20) . Although toxoplasmosis is in general clinically asymptomatic in healthy individuals, it may cause severe complications in the offspring of acutely infected pregnant women and in immunocompromised patients. T. gondii is recognized as a major opportunistic pathogen and the most common cause of focal intracerebral lesions in patients with AIDS (12) . In this group of individuals, disruption of cysts that persist in multiple tissues after primary infection, with release of proliferative forms of the parasite, causes severe disseminated toxoplasmosis and encephalitis (10, 21) .
The importance of cytokines in inducing anti-toxoplasma activity in macrophages is well established (7, 15, 18) . A number of studies have demonstrated the role of gamma interferon (IFN-y) in inducing intracellular killing of toxoplasmas in macrophages (15, 18, 23) . Alternatively, previous studies showed that treatment of toxoplasma-infected macrophage monolayers with other cytokines, such as recombinant tumor necrosis factor alpha (TNF), had no effect on the intracellular survival of the parasite (9) . Coinfection of macrophages with T. gondii and Mycobacterium avium prevented the TNF-mediated mycobacteriostatic and mycobactericidal activity (6) observed in macrophages infected only with M. avium, suggesting that the presence of intracellular T. gondii may influence TNF mRNA by interfering with the signal transduction. To examine this question, we sought to determine the effect of T. gondii infection of macrophages on TNF receptors. * Corresponding author.
MATERIALS AND METHODS
Organism. T. gondii RH was maintained by serial passage in the peritoneal cavity of Swiss Webster mice. Tachyzoites were collected from the peritoneal cavity of infected mice as previously described (7) .
Murine macrophages. Murine macrophages were obtained as previously described (7, 15) . Briefly, peritoneal macrophages were harvested from 6-week-old female Swiss Webster mice (Simonson, Gilroy, Calif.) by injecting 5 ml of saline into the abdominal cavity and removing the cell suspension after 5 min. Adherent cells were cultivated in plastic tissue culture plates (Flow Laboratories, Inc., McLean, Va.) or on 12-mm glass coverslips in RPMI 1640 (GIBCO) containing 10% heat-inactivated fetal bovine serum (HyClone, Logan, Utah), penicillin (100 U/ml), and streptomycin (100 ,ug/ml) (standard medium). The preparation was more than 97% pure as assessed by the ability to absorb neutral red. Expression of TNF receptors on macrophages. Expression of TNF receptors on macrophages was determined as previously described (4) . Briefly, murine TNF was iodinated with Na'"I by the chloramine-T method (ICN, Costa Mesa, Calif.) to yield a specific activity of approximately 40 Ci/ml. The protein concentration of the preparation, estimated by trichloroacetic acid precipitation, exhibited full biological activity as evidenced by the L929 (TNF-sensitive cells) assay as previously described (5) .
The binding assay was performed as follows. Adherent macrophages were infected with T. gondii for 1 h, and the extracellular organisms were removed by washing. Expression of TNF receptors on macrophages was determined by adding 1`I-TNF ( Control experiments for nonspecific binding of the ligand were performed in wells in the presence of a 200-fold excess of unlabeled TNF. Equilibrium was achieved at 4°C, and the specific binding peaked in 3 h and declined thereafter. Measurements were performed in duplicate, and the background was always <20% of the total.
Concentration of TNF and TGF-13. The murine TNF concentration in the culture supematant was measured by an enzyme-linked immunosorbent assay (Genzyme, Cambridge, Mass.). The MVILu mink lung cell line (American Type Culture Collection, Rockville, Md.) was used to measure TGF-3 activity as previously described (22) . Supernatants were assayed either untreated or after treatment with 0.12 N HCl for 15 min at room temperature followed by neutralization with 0. macrophages expressed significantly fewer receptors for TNF than did control macrophages and infected macrophages at 1 h after infection (P < 0.05).
Effect of supernatant on TNF binding. Since not all macrophages in the monolayers were infected with T. gondii (we determined that in these experiments approximately 50 to 60% of the cells were infected), it seemed plausible to hypothesize that the observed downregulation of expression of TNF receptors would be more significant if only infected cells were considered, unless the downregulation in the number of receptors was secondary to the secretion by infected cells of suppressor molecules that would then affect all macrophages in the monolayers. To examine this question, we carried out experiments with uninfected macrophages exposed to supernatants obtained from infected macrophage monolayers at 1, 2, and 6 h after infection. Culture supernatants were obtained, filtered through a filter (pore size, 0.22 ,um; Millipore, Bedford, Mass.), and then incubated with uninfected macrophages for a time. Then supernatant was removed, and the expression of TNF receptors was determined. As shown in Table 1 , incubation of uninfected macrophages with such supernatants was associated with significant downregulation of the expression of TNF receptors. However, a significant decrease in the number of receptors was observed only following incubation for between 2 and 6 h. Of note, the decrease in 125I-TNF binding to monolayers exposed to supernatants was compa- IFN-y (8, 24) , we examined whether production of TGF-p1 increased in macrophages infected with T. gondii and also measured TNF production by the same macrophages.
As shown in Table 2 , macrophages infected with T. gondii produce high concentrations of TGF-p1. Interestingly, most of the released TGF-13 was found in a biologically active form (Table 2 ). In addition, TGF-j31 was detected in the supernatants of the monolayers as early as 2 h following infection.
Infected macrophages were also shown to produce TNF. However, release of TNF was greater after 2 h of infection and decreased subsequently.
Effect of anti-TGF-I3 antibody on T. gondii-mediated downregulation of TNF receptors. To determine whether release of TGF-P1 T. gondii-infected macrophages was related to the downregulation of TNF receptors, we carried out experiments with anti-TGF-P, antibody. Anti-TGF-P, antibody was added to macrophage monolayers at time zero (immediately before addition of toxoplasmas to monolayers), and expression of TNF receptors was determined 2, 6, and 20 h after infection with T. gondii.
The results, shown in Fig. 3 , demonstrate that the presence of anti-TGF-P1 antibody had a significant effect on the expression of TNF receptors by infected macrophages.
Anti-TGF-P1 antibody partially inhibited the T. gondii-mediated suppression of TNF binding, with a more significant effect observed at 20 h after infection.
Anti-TGF-1,3 had no significant effect on tachyzoite proliferation during the 6 h of the assay. DISCUSSION T. gondii is an intracellular parasite, capable of invading and surviving in a number of mammalian cells (19, 20) . Previous studies have demonstrated that human peritoneal macrophages, while allowing infection by T. gondii, consistently demonstrated toxoplasmacidal activity (11) . In contrast, mouse macrophages are unable to kill T. gondii and require activation with cytokines to do so (6, 8) . However, a study by Murray et al. (16) showed that macrophages obtained from patients with AIDS fail to inhibit or kill intracellular T. gondii but can be stimulated to do so in vitro when treated with recombinant IFN--y.
Results of previous studies have indicated that IFN-y is a critical cytokine for induction of toxoplasmacidal activity in macrophages, although it has been suggested that costimulation with TNF is required to obtain maximal IFN-y effect (14) . Despite this, TNF by itself does not have the ability to activate murine macrophages in vitro to kill T. gondii (9) , and, at least in one system, M. avium infection together with T. gondii causes macrophages to become unresponsive to subsequent stimulation with TNF (6 (25) , and, once inside the vacuole, they inhibit phagosome-lysosome fusion (13) . Our present findings that infection of macrophages with T. gondii induces production and release of TGF-31 add to the previously known mechanisms associated with intracellular survival of the parasite. Production of TGF-p1, mostly in an active form, can explain at least in part the inability of recombinant TNF to activate macrophages to kill intracellular T. gondii. In addition, the observed suppression of TNF receptors following infection prevents a possible autocrine effect of TNF on infected cells. In fact, similar observations obtained with in vitro and in vivo models of Leishmania (2) and Trypanozoma cruzi (22) infections are consistent with the hypothesis that intracellular pathogens are capable of inducing the production of suppressive molecules such as TGF-,B and interleukin-10, which would impair the microbicidal activity of macrophages. Our findings are also consistent with previously published results by us and others (15, 17) that the ability of recombinant IFN--y to activate macrophages to kill T. gondii is significantly greater if monolayers are treated with IFN-y before rather than after infection, indicating that infection with T. gondii is associated with macrophage unresponsiveness to subsequent stimulation. Although previous studies have demonstrated that TGF-, inhibits the macrophage response to IFN--y and TNF, results of our experiments involving anti-TGF-1,3 antibody suggest the presence of other inhibitory mechanisms.
It is interesting to speculate that the ability to trigger the production of suppressive molecules (such as TGF-,B) in macrophages may vary with the strain of T. gondii and with the macrophage population and perhaps can explain differences in susceptibility to toxoplasma infection between mouse and human macrophages (11) .
